Stereotaxis Inc Stock Other OTC
Stocks
US85916J4094
Advanced Medical Equipment & Technology
| Market Cap | 118M 105M 98.05M 89.37M 169M 11.37B 170M 1.19B 460M 5.81B 444M 434M 18.65B | P/E 2026 * |
-5.8x | P/E 2027 * | -8.05x |
|---|---|---|---|---|---|
| Enterprise Value | 118M 105M 98.05M 89.37M 169M 11.37B 170M 1.19B 460M 5.81B 444M 434M 18.65B | EV / Sales 2026 * |
3.44x | EV / Sales 2027 * | 2.59x |
| Free-Float |
84.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Stereotaxis Inc
| 1 day | -5.62% |
| Manager | Title | Age | Since |
|---|---|---|---|
David Fischel
CEO | Chief Executive Officer | - | 03/02/2017 |
Kimberly Peery
DFI | Director of Finance/CFO | 57 | 01/10/2019 |
Keith Galloway
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Benfer
BRD | Director/Board Member | 79 | 01/02/2005 |
David Fischel
CHM | Chairman | - | 03/02/2017 |
Arun Menawat
BRD | Director/Board Member | 71 | 29/09/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.62% | +10.41% | - | - | 118M | |
| +0.35% | -2.99% | +24.73% | +32.07% | 242B | |
| +1.09% | -4.65% | +1.77% | +0.15% | 150B | |
| -2.32% | -3.27% | -11.53% | +32.87% | 138B | |
| -1.46% | -3.01% | -55.73% | -19.33% | 61.74B | |
| -0.05% | -1.32% | +11.09% | +23.08% | 49.08B | |
| +0.66% | +0.19% | -19.29% | -21.24% | 47.43B | |
| +0.66% | -2.90% | +20.97% | +51.29% | 47.3B | |
| -3.05% | -2.62% | -9.13% | +35.86% | 44.25B | |
| -0.08% | -1.92% | +32.09% | +57.18% | 41.78B | |
| Average | -0.72% | -2.50% | -0.56% | +21.33% | 91.4B | |
| Weighted average by Cap. | +0.15% | -3.27% | +3.37% | +21.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 34.33M 30.51M 28.47M 25.95M 48.94M 3.3B 49.4M 345M 134M 1.69B 129M 126M 5.42B | 45.67M 40.57M 37.87M 34.52M 65.1M 4.39B 65.71M 458M 178M 2.24B 171M 168M 7.2B |
| Net income | -20.13M -17.89M -16.7M -15.22M -28.7M -1.94B -28.97M -202M -78.29M -989M -75.59M -73.95M -3.18B | -14.77M -13.12M -12.25M -11.16M -21.05M -1.42B -21.25M -148M -57.42M -726M -55.44M -54.24M -2.33B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
